Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada [Yahoo! Finance]
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.60 to $6.20. They now have a "buy" rating on the stock.
Vivos Therapeutics, Inc. (NASDAQ: VVOS) had its "buy" rating re-affirmed by analysts at Alliance Global Partners.
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update